FEATURES: Doctors' Orders: The government's war on medical "price fixing" squelches speech without helping consumers
In: Reason: free minds and free markets, Band 42, Heft 7, S. 44-51
ISSN: 0048-6906
3 Ergebnisse
Sortierung:
In: Reason: free minds and free markets, Band 42, Heft 7, S. 44-51
ISSN: 0048-6906
This paper presents a part of a wide investigation. The main object was to propose Political Actions to the policymakers to favor the labor insertion of women in professions where women are under-represented. This paper is an attempt to study in depth the employers' behavior to find their degree of responsibility and influence in the sex segregation in the labor market. A qualitative study was made. The results show us that the sensibility to the issue is raised. Entrepreneurs believe that the situation is not fair, but they do not feel it is their responsibility to make the changes. They ask a higher participation from the Government and from Society in general, and at the same time they recognize that they do not know the political movements such as affirmative action.
BASE
Objective: To assess the risk of mycotoxin exposure (aflatoxin M1, ochratoxin A, and zearalenone) in celiac disease (CD) breastfeeding mothers and healthy control mothers, as well as in their offspring, by quantifying these contaminants in breast milk. Study design: Thirty-five breastfeeding women with CD on a gluten-free diet and 30 healthy breastfeeding controls were recruited. Milk sampling was performed three times per day for three consecutive days. Mycotoxin content was investigated by an analytical method using immunoaffinity column clean-up and high-performance liquid chromatography (HPLC) with fluorometric detection. Results: Aflatoxin M1 (AFM1) was detected in 37% of CD group samples (mean ± SD = 0.012 ± 0.011 ng/mL; range = 0.003-0.340 ng/mL). The control group showed lower mean AFM1 concentration levels in 24% of the analyzed samples (0.009 ± 0.007 ng/mL; range = 0.003-0.067 ng/mL, ANOVA on ranks, p-value < 0.01). Ochratoxin A and zearalenone did not differ in both groups. Conclusion: Breast milk AFM1 contamination for both groups is lower than the European safety threshold. However, the estimated exposures of infants from CD mothers and control mothers was much higher (≃15 times and ≃11 times, respectively) than the threshold set by the joint FAO/WHO Expert Committee on Food Additives (JECFA). Since incongruities exist between JECFA and the European Union standard, a novel regulatory review of the available data on this topic is desirable. Protecting babies from a neglected risk of high AFM1 exposure requires prompt regulatory and food-control policies.
BASE